Atossa Genetics changes name to Atossa Therapeutics

First Name*
Last Name*
Business Email *
Phone *
Company Name *

City *

Yes, I would like to receive promotional emails containing essential industry insights, event invitations, and relevant solutions from S&P Global Market Intelligence.

We generated a verification code for you
Enter verification Code here*

* Required

Clicking 'Request' means you agree to the Terms and have read and understood the Privacy Policy

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

Investment Management Investment Banking & Private Equity Commercial Banking & Insurance Corporations Governments & Regulatory Agencies Academia Professional Services

Latest in Industry Segments
Read: IFRS 9: Time is Running Out for Insurance Companies to Comply
Many lessons were learned from the 2007-2008 financial crisis, including the need to better understand an organization’s expected credit losses (ECLs).
Read: Opportunities And Challenges For African Telecommunications Industry At Africacom 2018
Pay TV, broadcasting, sports rights, affordability, connectivity and innovation were at the center of the conversation at AfricaCom 2018, held Nov. 13-15 in Cape Town, South Africa. Executives presented exciting initiatives for this 90 million TV households market.
Read: Cable Networks Q2'19 Distribution Revenue Recap
Despite subscriber declines, total distribution revenues reported by the eight publicly traded cable network owners tracked by Kagan for Q2 grew by 4.3% to $10.26 billion, due in large part to built-in contractual rate increases.
I Need Data to make informed decisions Tools to manage credit risk Real-time news and insights In-depth research Regulatory solutions ESG analysis See More
Capabilities Credit Analytics RatingsDirect^® RatingsXpress^® Commercial Prospecting Leveraged Commentary & Data View All Capabilities >
Delivery Market Intelligence Platform S&P Capital IQ Platform Data Management & Feed Solutions Daily Dose Panjiva Platform
Latest News Headlines Blog Research Videos Podcasts Topics Media Center

Latest News & Insights
Read: IFRS 9: Time is Running Out for Insurance Companies to Comply
Many lessons were learned from the 2007-2008 financial crisis, including the need to better understand an organization’s expected credit losses (ECLs).
Read: Opportunities And Challenges For African Telecommunications Industry At Africacom 2018
Pay TV, broadcasting, sports rights, affordability, connectivity and innovation were at the center of the conversation at AfricaCom 2018, held Nov. 13-15 in Cape Town, South Africa. Executives presented exciting initiatives for this 90 million TV households market.
Read: Cable Networks Q2'19 Distribution Revenue Recap
Despite subscriber declines, total distribution revenues reported by the eight publicly traded cable network owners tracked by Kagan for Q2 grew by 4.3% to $10.26 billion, due in large part to built-in contractual rate increases.
All Events In-Person Events Webinars Webinar Replays
Featured Events
ConferenceThe Essential Conference
- 02/01/2021
- Austin, Texas
- Kimpton Hotel Van Zandt
SeminarsREIT School 2020: Analyst Training In Real Estate Investment Trusts
- 06/23/2020
- Chicago, IL
- The Gleacher Center
ConferenceThe Kagan Media Summit
- 06/18/2020
- New York, NY
- Hotel Edison
Platforms Market Intelligence Platform S&P Capital IQ Platform
Other Products Credit Analytics Leveraged Commentary and Data Money Market Directories
Research Online S&P Dow Jones Indices Panjiva

In This List

Atossa Genetics changes name to Atossa Therapeutics

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

8 Jan, 2020

Author Ephraim Bie
Theme Healthcare & Pharmaceuticals

Atossa Genetics Inc., a Seattle-based biopharmaceutical company, changed its name to Atossa Therapeutics Inc.

The company said the name change more clearly reflects its focus on developing therapies for breast cancer, breast density and other breast conditions.

Atossa's common stock will continue to trade on the NasdaqCM exchange under the ATOS symbol.

Login to Market Intelligence Platform

Atossa Genetics changes name to Atossa Therapeutics